Annual Accounts Payable
$376.30 K
+$219.20 K+139.53%
June 30, 2024
Summary
- As of February 7, 2025, NNVC annual accounts payable is $376.30 thousand, with the most recent change of +$219.20 thousand (+139.53%) on June 30, 2024.
- During the last 3 years, NNVC annual accounts payable has risen by +$176.30 thousand (+88.15%).
- NNVC annual accounts payable is now -71.52% below its all-time high of $1.32 million, reached on June 30, 2010.
Performance
NNVC Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.35 M
+$253.10 K+23.09%
September 1, 2024
Summary
- As of February 7, 2025, NNVC quarterly accounts payable is $1.35 million, with the most recent change of +$253.10 thousand (+23.09%) on September 1, 2024.
- Over the past year, NNVC quarterly accounts payable has increased by +$794.90 thousand (+143.35%).
- NNVC quarterly accounts payable is now at all-time high.
Performance
NNVC Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
NNVC Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +139.5% | +143.3% |
3 y3 years | +88.2% | +245.6% |
5 y5 years | +21.4% | +245.6% |
NNVC Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +548.8% | at high | +3479.3% |
5 y | 5-year | -1.2% | +548.8% | at high | +3479.3% |
alltime | all time | -71.5% | +675.9% | at high | +5666.7% |
NanoViricides Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $1.35 M(+23.1%) |
Jun 2024 | $376.30 K(+139.5%) | $1.10 M(+97.7%) |
Mar 2024 | - | $554.50 K(+107.9%) |
Dec 2023 | - | $266.70 K(+16.4%) |
Sep 2023 | - | $229.20 K(-41.3%) |
Jun 2023 | $157.10 K(+170.9%) | $390.50 K(+522.8%) |
Mar 2023 | - | $62.70 K(+59.5%) |
Dec 2022 | - | $39.30 K(+4.2%) |
Sep 2022 | - | $37.70 K(-35.0%) |
Jun 2022 | $58.00 K(-71.0%) | $58.00 K(-52.8%) |
Mar 2022 | - | $123.00 K(-19.7%) |
Dec 2021 | - | $153.20 K(+31.8%) |
Sep 2021 | - | $116.20 K(-41.9%) |
Jun 2021 | $200.00 K(-47.5%) | $200.00 K(+103.7%) |
Mar 2021 | - | $98.20 K(-46.9%) |
Dec 2020 | - | $185.10 K(-28.3%) |
Sep 2020 | - | $258.20 K(-32.2%) |
Jun 2020 | $380.70 K(+22.8%) | $380.70 K(-7.2%) |
Mar 2020 | - | $410.20 K(-39.0%) |
Dec 2019 | - | $672.40 K(+2.4%) |
Sep 2019 | - | $656.80 K(+111.9%) |
Jun 2019 | $309.90 K(+38.8%) | $309.90 K(+25.6%) |
Mar 2019 | - | $246.70 K(+10.2%) |
Dec 2018 | - | $223.80 K(-30.1%) |
Sep 2018 | - | $320.10 K(+43.3%) |
Jun 2018 | $223.30 K(+64.4%) | $223.30 K(+14.2%) |
Mar 2018 | - | $195.50 K(+157.9%) |
Dec 2017 | - | $75.80 K(-16.2%) |
Sep 2017 | - | $90.40 K(-33.4%) |
Jun 2017 | $135.80 K(+40.7%) | $135.80 K(+20.5%) |
Mar 2017 | - | $112.70 K(-10.6%) |
Dec 2016 | - | $126.10 K(-53.2%) |
Sep 2016 | - | $269.40 K(+179.2%) |
Jun 2016 | $96.50 K(+7.8%) | $96.50 K(+34.2%) |
Mar 2016 | - | $71.90 K(-59.2%) |
Dec 2015 | - | $176.20 K(+201.2%) |
Sep 2015 | - | $58.50 K(-34.6%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2015 | $89.50 K(-76.2%) | $89.50 K(+282.5%) |
Mar 2015 | - | $23.40 K(-95.3%) |
Dec 2014 | - | $502.00 K(+221.8%) |
Sep 2014 | - | $156.00 K(-58.6%) |
Jun 2014 | $376.40 K(+43.0%) | $376.40 K(+47.6%) |
Mar 2014 | - | $255.00 K(+4.4%) |
Dec 2013 | - | $244.30 K(-40.1%) |
Sep 2013 | - | $408.10 K(+55.0%) |
Jun 2013 | $263.30 K(+10.4%) | $263.30 K(+10.8%) |
Mar 2013 | - | $237.70 K(-75.1%) |
Dec 2012 | - | $953.20 K(+15.5%) |
Sep 2012 | - | $825.50 K(+246.3%) |
Jun 2012 | $238.40 K(-56.1%) | $238.40 K(-59.9%) |
Mar 2012 | - | $593.90 K(-38.5%) |
Dec 2011 | - | $965.20 K(+19.4%) |
Sep 2011 | - | $808.20 K(+49.0%) |
Jun 2011 | $542.50 K(-58.9%) | $542.50 K(-31.3%) |
Mar 2011 | - | $789.10 K(-28.5%) |
Dec 2010 | - | $1.10 M(+31.0%) |
Sep 2010 | - | $843.20 K(-36.2%) |
Jun 2010 | $1.32 M(+194.9%) | $1.32 M(+42.0%) |
Mar 2010 | - | $930.70 K(-20.8%) |
Dec 2009 | - | $1.18 M(+159.6%) |
Sep 2009 | - | $452.70 K(+1.0%) |
Jun 2009 | $448.00 K(-33.1%) | $448.00 K(-1.1%) |
Mar 2009 | - | $453.20 K(-15.3%) |
Dec 2008 | - | $535.20 K(-34.4%) |
Sep 2008 | - | $815.90 K(+21.8%) |
Jun 2008 | $669.90 K(+100.0%) | $669.90 K(+185.8%) |
Mar 2008 | - | $234.40 K(+71.3%) |
Dec 2007 | - | $136.80 K(-43.2%) |
Sep 2007 | - | $240.80 K(-28.1%) |
Jun 2007 | $334.90 K(+35.5%) | $334.90 K(-1.9%) |
Mar 2007 | - | $341.40 K(+7.1%) |
Dec 2006 | - | $318.70 K(+75.4%) |
Sep 2006 | - | $181.70 K(-26.5%) |
Jun 2006 | $247.10 K(+409.5%) | $247.10 K |
Jun 2005 | $48.50 K | - |
FAQ
- What is NanoViricides annual accounts payable?
- What is the all time high annual accounts payable for NanoViricides?
- What is NanoViricides annual accounts payable year-on-year change?
- What is NanoViricides quarterly accounts payable?
- What is the all time high quarterly accounts payable for NanoViricides?
- What is NanoViricides quarterly accounts payable year-on-year change?
What is NanoViricides annual accounts payable?
The current annual accounts payable of NNVC is $376.30 K
What is the all time high annual accounts payable for NanoViricides?
NanoViricides all-time high annual accounts payable is $1.32 M
What is NanoViricides annual accounts payable year-on-year change?
Over the past year, NNVC annual accounts payable has changed by +$219.20 K (+139.53%)
What is NanoViricides quarterly accounts payable?
The current quarterly accounts payable of NNVC is $1.35 M
What is the all time high quarterly accounts payable for NanoViricides?
NanoViricides all-time high quarterly accounts payable is $1.35 M
What is NanoViricides quarterly accounts payable year-on-year change?
Over the past year, NNVC quarterly accounts payable has changed by +$794.90 K (+143.35%)